BIO SB Products and Technology for Molecular Pathology

Bio SB performs R&D, production, distribution of antibodies and detection systems for immunohistochemistry (IHC), including environmentally friendly ancillaries, unique IVD validated antibodies, detection systems and equipment. Our portfolio includes products for immunohistochemistry (IHC) immunocytochemistry (ICC), Immunofluorescence (IF), chromogenic in situ hybridization (CISH) and fluorescent in situ hybridization (FISH) technologies that meet the highest international standards for applications in molecular pathology, cancer research, microbiology, immunology and genetics. Bio SB manufactures and develops products in accordance with FDA QSR 21 CFR Part 820 cGMP, CE IVD and ISO13485:2016 certifications.

Upcoming Events

October, 2021FedPatMex virtual Convention. Dr Heras to present a talkĀ about Development of SARS-CoV-2 IHC to assess the Pathogenesis, Cytokine Storm Syndrome and CoagulopathyWebinar
September, 2021NSH Mohs IHC workshop sponsored by Bio SB & conducted by Jonathan Hetts of Oregon StateWorkshop
April 29th – May 2nd, 202052nd Annual Convention of the Mexican Association of Pathology, Guadalajara, MexicoWebsite
April 24th – 29th, 2020AACR 2020 Annual Meeting, San Diego, CaliforniaWebsite
April 23rd – 26th, 2020American College of Mohs Surgery 2020 Annual Meeting, Nashville, TennesseeWebsite
February 29th – March 5th, 2020USCAP 2020 Annual Meeting, Los Angeles, CaliforniaWebsite